Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments

被引:21
|
作者
Augustovski, Federico [1 ]
Belizan, Maria [1 ]
Gibbons, Luz [1 ]
Reyes, Nora [2 ]
Stolk, Elly [3 ]
Craig, Benjamin M. [4 ]
Tejada, Romina A. [2 ]
机构
[1] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina
[2] Inst Nacl Salud, Unidad Anal & Generac Evidencias Salud Publ, Lima, Peru
[3] EuroQol Res Fdn, Rotterdam, Netherlands
[4] Univ S Florida, Tampa, FL 33620 USA
关键词
discrete choice experiment; EuroQol; preference elicitation methods; time trade off; utility assessment; HEALTH-STATE VALUATIONS; ADJUSTED LIFE-YEARS; VALUE SET;
D O I
10.1016/j.jval.2020.05.004
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: (1) To produce Peruvian general population EQ-5D-5L value sets on a quality-adjusted life-year scale, (2) to investigate the feasibility of a "Lite" protocol less reliant on the composite time trade-off (cTTO), and (3) to compare cTTO and discrete choice experiment (DCE) value sets. Methods: A random sample of adults (N = 1000) in Lima, Arequipa, and Iquitos did a home interview; 300 were randomly selected to complete 11 cTTOs first. All respondents completed a DCE, including 10 latent-scale pairs (A/B) with 5 EQ-5D-5L attributes, and 12 matched pairs (A/B and B/C) with 5 EQ-5D-5L and one lifespan attributes. We estimated a cTTO heteroscedastic tobit (N = 300) model and 3 DCE Zermelo-Bradley-Terry models (N = 300, 700, and 1000). Results: Each model produced a consistent value set (20 positive incremental parameters). Nevertheless, their lowest quality-adjusted life-year values differed greatly (cTTO: -1.076 [N = 300]; DCE: -0.984 [300], 0.048 [700], -0.213 [1000]). Compared with the cTTO, the DCE (N = 300) produced different parameters (Pearson's correlation = 0.541), fewer insignificant parameters (0 vs 8), and fewer values less than 0 (26% vs 44%). Compared with the DCE (N = 300), the DCE (N = 700) produced higher values but similar parameters (Pearson's correlation = 0.800). Conclusions: Besides producing EQ-5D-5L value sets for Peru, the results casts doubt about the feasibility of a Lite protocol like the one in this study. Additionally, fundamental differences between cTTO and DCE-without the existence of a gold standard-need further clarification. The choice between the two rational value sets produced in the current study is a matter of judgment and may have substantial policy implications.
引用
收藏
页码:880 / 888
页数:9
相关论文
共 50 条
  • [31] EQ-5D-5L Valuation for the Malaysian Population
    Asrul Akmal Shafie
    Annushiah Vasan Thakumar
    Ching Jou Lim
    Nan Luo
    Kim Rand-Hendriksen
    Faridah Aryani Md Yusof
    [J]. PharmacoEconomics, 2019, 37 : 715 - 725
  • [32] The EQ-5D-5L Valuation study in Thailand
    Pattanaphesaj, Juntana
    Thavorncharoensap, Montarat
    Ramos-Goni, Juan Manuel
    Tongsiri, Sirinart
    Ingsrisawang, Lily
    Teerawattananon, Yot
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (05) : 551 - 558
  • [33] The EQ-5D-5L Valuation Study in Egypt
    Al Shabasy, Sahar A.
    Abbassi, Maggie M.
    Finch, Aureliano Paolo
    Baines, Darrin
    Farid, Samar F.
    [J]. PHARMACOECONOMICS, 2022, 40 (04) : 433 - 447
  • [34] The EQ-5D-5L valuation study in Korea
    Kim, Seon-Ha
    Ahn, Jeonghoon
    Ock, Minsu
    Shin, Sangjin
    Park, Jooyeon
    Luo, Nan
    Jo, Min-Woo
    [J]. QUALITY OF LIFE RESEARCH, 2016, 25 (07) : 1845 - 1852
  • [35] The EQ-5D-5L Valuation Study in Egypt
    Sahar Al Shabasy
    Maggie Abbassi
    Aureliano Finch
    Bram Roudijk
    Darrin Baines
    Samar Farid
    [J]. PharmacoEconomics, 2022, 40 : 433 - 447
  • [36] The Utility of 5 Hypothetical Health States in Heart Failure Using Time Trade-Off (TTO) and EQ-5D-5L in Korea
    Hong, Sung-Hyun
    Lee, Jae-Yeon
    Park, Sun-Kyeong
    Nam, Jin Hyun
    Song, Hyun Jin
    Park, Sun-Young
    Lee, Eui-Kyung
    [J]. CLINICAL DRUG INVESTIGATION, 2018, 38 (08) : 727 - 736
  • [37] The Utility of 5 Hypothetical Health States in Heart Failure Using Time Trade-Off (TTO) and EQ-5D-5L in Korea
    Sung-Hyun Hong
    Jae-Yeon Lee
    Sun-Kyeong Park
    Jin Hyun Nam
    Hyun Jin Song
    Sun-Young Park
    Eui-Kyung Lee
    [J]. Clinical Drug Investigation, 2018, 38 : 727 - 736
  • [38] VALUING EQ-5D-5L USING DISCRETE CHOICE EXPERIMENTS WITH DURATION: INVESTIGATING DIMENSION ORDER
    Mulhern, B.
    Norman, R.
    Viney, R.
    Lorgelly, P.
    Lancsar, E.
    Ratcliffe, J.
    Brazier, J.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A94 - A94
  • [39] United States Valuation of the EQ-5D-5L
    Craig, Benjamin M.
    Rand-Hendriksen, Kim
    [J]. QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 48 - 48
  • [40] A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada
    Xie, Feng
    Pullenayegum, Eleanor
    Gaebel, Kathy
    Bansback, Nick
    Bryan, Stirling
    Ohinmaa, Arto
    Poissant, Lise
    Johnson, Jeffrey A.
    [J]. MEDICAL CARE, 2016, 54 (01) : 98 - 105